REL and inflammatory bowel disease: Current genome‐wide association studies investigating IBD cohorts have not addressed whether risk alleles for IBD also alter an individual's susceptibility to colitis‐associated cancer, and at present, there are no published data on whether known polymorphisms at the REL locus influence the risk of either colitis‐associated cancer or sporadic colorectal cancer in humans.